TTOO stock forecast
Our latest prediction for T2 Biosystems Inc's stock price was made on the Oct. 3, 2023 when the stock price was at 0.22$.
In the short term (2weeks), TTOO's stock price should underperform the market by -2.44%. During that period the price should oscillate between -13.98% and +12.51%.
In the medium term (3months), TTOO's stock price should underperform the market by -1.08%. During that period the price should oscillate between -31.48% and +27.75%.Get email alerts
Create a solid portfolio with TTOO
About T2 Biosystems Inc
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -4.45$ per share.
The book value per share is 0.73$
Three months stock forecastOct. 3, 2023
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|